Pfizer, maker of Viagra, will combine with EpiPen maker Mylan

Pfizer, the world’s largest drugmaker, plans to divest its off-patent drug business and combine it with generic-drug maker Mylan.
Under the terms of the agreement, which is structured as an all-stock deal, each Mylan share would be converted into one share of the new company.
In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif.Rich Pedroncelli / AP
Pfizer shareholders would own 57 percent of the combined